Varex Imaging Stock (NASDAQ:VREX)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$10.53

52W Range

$6.76 - $14.56

50D Avg

$10.88

200D Avg

$11.83

Market Cap

$464.36M

Avg Vol (3M)

$363.14K

Beta

0.90

Div Yield

-

VREX Company Profile


Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2,300

IPO Date

Jan 23, 2017

Website

VREX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceSep 24Sep 23Sep 22
Medical Segment$581.70M$673.30M-
Industrial Segment$229.30M$220.10M-
Industrial--$184.70M
Medical--$674.70M

Fiscal year ends in Oct 25 | Currency in USD

VREX Financial Summary


Oct 25Sep 24Sep 23
Revenue$844.60M$811.00M$893.40M
Operating Income$-27.80M$32.10M$77.10M
Net Income$-70.30M$-47.70M$48.20M
EBITDA$-27.80M$62.90M$94.70M
Basic EPS$-1.70$-1.17$1.20
Diluted EPS$-1.70$-1.17$1.08

Fiscal year ends in Oct 25 | Currency in USD

Latest Earnings Call Transcripts


Q2 26May 07, 26 | 12:00 AM
Q1 26Feb 11, 26 | 12:00 AM
Q4 25Nov 18, 25 | 5:00 PM

Peer Comparison


TickerCompany
SYSo-Young International Inc.
CBLLCeriBell, Inc.
BCYCBicycle Therapeutics plc
CTKBCytek Biosciences, Inc.
OMEROmeros Corporation
LXRXLexicon Pharmaceuticals, Inc.
AVNSAvanos Medical, Inc.
LABStandard BioTools Inc.
CGEMCullinan Therapeutics, Inc.
OFIXOrthofix Medical Inc.